25 news items
Page 2 of 2
xz8w8d313e00ip6ybo2h
SAGE
17 Apr 24
Wedbush analyst Laura Chico reiterates Sage Therapeutics (NASDAQ:SAGE) with a Neutral and maintains $24 price target.
jt1uueww5tz k9y33gqb8xakcbgmbmxmxjln
SAGE
17 Apr 24
(NASDAQ:SAGE) from Neutral to Underperform and lowers the price target from $24 to $14.
mbkih49j2c9ij6wkwagybqt7l5yfke 3ig113ny6vqufn9hji3
SAGE
17 Apr 24
and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find out
v5mf7co4l50ltayyi37
SAGE
11 Apr 24
depression and is advancing a robust pipeline to target unmet needs in brain health. Sage was founded in 2010 and is headquartered in Cambridge, Mass. Find
2bx9obnos7t42n2cf8s6vee6ugpk9qk32rld51iwro0 3ebaimbct
SAGE
26 Mar 24
Analysts' evaluations of 12-month price targets offer additional insights, showcasing an average target of $26.2